A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. (Q40462635)

20 September 2017

A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. (English)

1 reference

20 September 2017

Lawrence O Flowers

1

1 reference

20 September 2017

Prem S Subramaniam

series ordinal

2

1 reference

20 September 2017

Howard M Johnson

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

2114-2120

1 reference

20 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208437

20 September 2017

0 references

cites work

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Expression of a tyrosine phosphorylated, DNA binding Stat3beta dimer in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

STAT proteins: From normal control of cellular events to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Epidemiology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Hormone-refractory prostate cancer: a multi-step and multi-event process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Environmental, genetic, and molecular features of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Stat3 activation in prostatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Interleukin-6 is an autocrine growth factor in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Signaling through the JAK/STAT pathway, recent advances and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Suppressors of cytokine signalling: SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Activation of the human androgen receptor through a protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Molecular alterations associated with LNCaP cell progression to androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Structural requirements for agonist activity of a murine interferon-gamma peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

Characterization of the role of IL-6 in the progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

inferred from DOI database lookup

7 January 2021

based on heuristic

The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

inferred from DOI database lookup

7 January 2021

based on heuristic

IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208437

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208437

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference